Kathleen M. Frey

1.1k total citations
38 papers, 882 citations indexed

About

Kathleen M. Frey is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Kathleen M. Frey has authored 38 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 14 papers in Virology and 13 papers in Molecular Biology. Recurrent topics in Kathleen M. Frey's work include HIV/AIDS drug development and treatment (17 papers), HIV Research and Treatment (14 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Kathleen M. Frey is often cited by papers focused on HIV/AIDS drug development and treatment (17 papers), HIV Research and Treatment (14 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Kathleen M. Frey collaborates with scholars based in United States and Belgium. Kathleen M. Frey's co-authors include Amy C. Anderson, Karen S. Anderson, William L. Jorgensen, Dennis L. Wright, Krasimir A. Spasov, Mariela Bollini, Bruce R. Donald, Ivelin S. Georgiev, Ricardo Gallardo‐Macias and Michael N. Lombardo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Kathleen M. Frey

38 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen M. Frey United States	19	429	362	186	183	174	38	882
Ester Muraglia Italy	18	709 1.7×	290 0.8×	483 2.6×	159 0.9×	130 0.7×	40	1.4k
Hsu‐Tso Ho United States	15	326 0.8×	370 1.0×	293 1.6×	250 1.4×	120 0.7×	17	935
Michael Klemba United States	24	794 1.9×	242 0.7×	133 0.7×	71 0.4×	401 2.3×	39	2.3k
David L. Akey United States	22	844 2.0×	485 1.3×	166 0.9×	69 0.4×	176 1.0×	31	1.7k
Joaquín Rullás Spain	18	413 1.0×	362 1.0×	105 0.6×	128 0.7×	290 1.7×	24	947
Abhai K. Tripathi United States	26	415 1.0×	239 0.7×	98 0.5×	64 0.3×	160 0.9×	61	2.1k
David I. Rhodes Australia	17	346 0.8×	399 1.1×	171 0.9×	545 3.0×	139 0.8×	31	1.1k
Laurence Berry France	25	585 1.4×	166 0.5×	231 1.2×	80 0.4×	545 3.1×	66	1.9k
Ayşegül Özen United States	16	309 0.7×	373 1.0×	51 0.3×	249 1.4×	151 0.9×	22	744
Íñigo Angulo‐Barturen Spain	22	471 1.1×	475 1.3×	240 1.3×	34 0.2×	258 1.5×	36	1.4k

Countries citing papers authored by Kathleen M. Frey

Since Specialization

Citations

This map shows the geographic impact of Kathleen M. Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen M. Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen M. Frey more than expected).

Fields of papers citing papers by Kathleen M. Frey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen M. Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen M. Frey. The network helps show where Kathleen M. Frey may publish in the future.

Co-authorship network of co-authors of Kathleen M. Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen M. Frey. A scholar is included among the top collaborators of Kathleen M. Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen M. Frey. Kathleen M. Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frey, Kathleen M., et al.. (2023). Crystal structure of dihydrofolate reductase from the filarial nematode W. bancrofti in complex with NADPH and folate. PLoS neglected tropical diseases. 17(4). e0011303–e0011303. 1 indexed citations

Frey, Kathleen M., Albert H. Chan, Joseph A. Ippolito, et al.. (2022). Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucleoside Inhibitors and Their Interactions With HIV-1 Reverse Transcriptase. Frontiers in Molecular Biosciences. 9. 805187–805187. 8 indexed citations

Frey, Kathleen M., et al.. (2021). Vericiguat: A Novel Oral Soluble Guanylate Cyclase Stimulator for the Treatment of Heart Failure. Annals of Pharmacotherapy. 56(5). 600–608. 9 indexed citations

Frey, Kathleen M., et al.. (2020). Limonene-induced activation of A2A adenosine receptors reduces airway inflammation and reactivity in a mouse model of asthma. Purinergic Signalling. 16(3). 415–426. 19 indexed citations

Frey, Kathleen M., et al.. (2020). Development of 3D-Printed Layered PLGA Films for Drug Delivery and Evaluation of Drug Release Behaviors. AAPS PharmSciTech. 21(7). 256–256. 28 indexed citations

Frey, Kathleen M., et al.. (2019). Current structure-based Methods for Designing non-nucleoside Reverse Transcriptase Inhibitors. Future Virology. 14(8). 537–544. 1 indexed citations

Frey, Kathleen M., et al.. (2018). A novel learning approach to pharmaceutical sciences research in a pharmacy research advanced pharmacy practice experience (APPE) elective course. Currents in Pharmacy Teaching and Learning. 10(11). 1529–1540. 4 indexed citations

Frey, Kathleen M., et al.. (2017). Structure-based methods to predict mutational resistance to diarylpyrimidine non-nucleoside reverse transcriptase inhibitors. Journal of Molecular Graphics and Modelling. 79. 133–139. 3 indexed citations

Frey, Kathleen M., et al.. (2015). Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants. Journal of Medicinal Chemistry. 58(6). 2737–2745. 41 indexed citations

10.

Frey, Kathleen M., Sarah B. Laskey, Krasimir A. Spasov, et al.. (2015). Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance. ACS Medicinal Chemistry Letters. 6(10). 1075–1079. 23 indexed citations

11.

Frey, Kathleen M., Ricardo Gallardo‐Macias, Krasimir A. Spasov, et al.. (2015). Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 25(21). 4824–4827. 18 indexed citations

12.

Frey, Kathleen M.. (2015). Structure-Enhanced Methods in the Development of Non-Nucleoside Inhibitors Targeting HIV Reverse Transcriptase Variants. Future Microbiology. 10(11). 1767–1772. 7 indexed citations

13.

Bollini, Mariela, Kathleen M. Frey, José A. Cisneros, et al.. (2013). Extension into the entrance channel of HIV-1 reverse transcriptase—Crystallography and enhanced solubility. Bioorganic & Medicinal Chemistry Letters. 23(18). 5209–5212. 33 indexed citations

14.

Viswanathan, Kishore, Kathleen M. Frey, Brooke D. Martin, et al.. (2012). Toward New Therapeutics for Skin and Soft Tissue Infections: Propargyl-Linked Antifolates Are Potent Inhibitors of MRSA and Streptococcus pyogenes. PLoS ONE. 7(2). e29434–e29434. 32 indexed citations

15.

Kim, Jiae, Ligong Wang, Yongfeng Li, et al.. (2012). Pre-steady state kinetic analysis of cyclobutyl derivatives of 2′-deoxyadenosine 5′-triphosphate as inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 22(12). 4064–4067. 7 indexed citations

16.

Frey, Kathleen M., Kishore Viswanathan, Dennis L. Wright, & Amy C. Anderson. (2012). Prospective Screening of Novel Antibacterial Inhibitors of Dihydrofolate Reductase for Mutational Resistance. Antimicrobial Agents and Chemotherapy. 56(7). 3556–3562. 24 indexed citations

17.

Frey, Kathleen M., Ivelin S. Georgiev, Bruce R. Donald, & Amy C. Anderson. (2010). Predicting resistance mutations using protein design algorithms. Proceedings of the National Academy of Sciences. 107(31). 13707–13712. 92 indexed citations

18.

Beierlein, Jennifer M., Lalit Deshmukh, Kathleen M. Frey, Olga Vinogradova, & Amy C. Anderson. (2009). The Solution Structure of Bacillus anthracis Dihydrofolate Reductase Yields Insight into the Analysis of Structure−Activity Relationships for Novel Inhibitors. Biochemistry. 48(19). 4100–4108. 9 indexed citations

19.

Frey, Kathleen M., Michael N. Lombardo, Dennis L. Wright, & Amy C. Anderson. (2009). Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase. Journal of Structural Biology. 170(1). 93–97. 42 indexed citations

20.

Beierlein, Jennifer M., Kathleen M. Frey, Phillip M. Pelphrey, et al.. (2008). Synthetic and Crystallographic Studies of a New Inhibitor Series Targeting Bacillus anthracis Dihydrofolate Reductase. Journal of Medicinal Chemistry. 51(23). 7532–7540. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact